Infliximab versus ciclosporin in severe ulcerative colitis

Lancet. 2012 Dec 1;380(9857):1887-8. doi: 10.1016/S0140-6736(12)61259-8. Epub 2012 Oct 10.
No abstract available

Publication types

  • Comment

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Antibodies, Monoclonal / therapeutic use*
  • Colitis, Ulcerative / drug therapy*
  • Cyclosporine / therapeutic use*
  • Female
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Infliximab
  • Male
  • Steroids / administration & dosage*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Antibodies, Monoclonal
  • Immunosuppressive Agents
  • Steroids
  • Cyclosporine
  • Infliximab